	Oral melanoma in the immunotherapy era: immune evasion, resistance, and therapeutic opportunities. Crit Rev Oncol Hematol de Arruda JAA, Drumond VZ, Sampaio GC, Xavier-Júnior JCC, Russo RC, Silva TA, de Andrade BAB. PMID: 42362073 [PubMed - as supplied by publisher]
	Unexpected melanoma metastasis with E-cadherin expression in bone marrow. J Hematop Pocci M. PMID: 42360677 [PubMed - indexed for MEDLINE]
	Implementing Paradigm Shifting Clinical Trials: Real-World Outcomes of Neoadjuvant Versus Adjuvant Immune Checkpoint Inhibitors in Advanced Melanoma Patients. Ann Surg Oncol Dougherty KE, Peery GB, Saravanan A, Pham VP, Herremans K, Moschos SJ, Collichio FA, Ollila DW. PMID: 42360644 [PubMed - as supplied by publisher]
	Predictive Value of Preoperative Positron Emission Tomography/Computed Tomography (PET/CT) in Staging of Patients with High-Risk Melanoma. Acta Dermatovenerol Croat Divo, Filipovi, Ko, , Divo, Filipovi, Ko, , Buljan M. PMID: 42359949 [PubMed - indexed for MEDLINE]
	Pilot study of topical imiquimod combined with pembrolizumab for unresectable cutaneous metastatic melanoma. Front Oncol Parker JB, Joseph RW, Suman VJ, Yan Y, Chen R. PMID: 42358556 [PubMed]
	Multimodal treatment and long-term survival in a rare case of melanoma with pancreatic and splenic metastases: a case report and literature review. Front Oncol Mou Y, Han L, Yu J, Shen H, Li H, Xu L, Li Q. PMID: 42358547 [PubMed]
	On the Progression From Early-to Late-Stage Melanoma: A Potential Sequence of Molecular Events Using Data From Droplet Digital PCR and Array Comparative Genomic Hybridization, A Pilot Study. Am J Dermatopathol McFadden JR, Htoo A, Chaudhari AS, Stevanovic M, Tsongalis GJ, Hughes EG, Sriharan A. PMID: 42358058 [PubMed - as supplied by publisher]
	Observational Study Profiling the Immune Microenvironment of Pregnancy-associated Melanoma. Am J Dermatopathol Kazmi M, Melloy MP, Abukhadra S, Terrell JR, Li Q, Zhu G, Tartar D, Keegan T, Maverakis E, Kiuru M. PMID: 42358002 [PubMed - as supplied by publisher]
	Immunotherapy for Melanoma: A Concise Clinical Review for Australasian Practice. Australas J Dermatol Stacy A, Wynn L, Seebacher N. PMID: 42357917 [PubMed - as supplied by publisher]
	Immunosuppressive Pathways in Cutaneous Melanoma: Functional Integration Between PD-1 and CD73 and Therapeutic Implications. Pharmaceuticals (Basel) Bertolucci RV, Klein B, Pase CC, de Melo VC, Bagatini MD. PMID: 42356529 [PubMed]
	The Influence of Dietary and Physical Exercise Habits on Melanoma Risk: A Case-Control Study. Nutrients Crespí-Payeras F, Moll-Amengual R, Calbet-Llopart N, Mateu J, Potrony M, Carrera C, Iglesias P, Tell-Martí G, Moral TT, Puig S. PMID: 42356305 [PubMed - indexed for MEDLINE]
	Assessment of Risk Factors Correlated with Satellites and In-Transit Metastases in Primary Cutaneous Melanomas. Medicina (Kaunas) Natarâ, T, Jurescu A, Vi, Cornea RF, Hurmuz I, Vidac A, Grujic D, Popa VT, Dema ALC. PMID: 42356028 [PubMed - indexed for MEDLINE]
	Current and Future Perspectives in Mohs Micrographic Surgery for Non-Melanoma Skin Cancers: A Narrative Review. J Clin Med Paradisi A, Brunetti F, Jeha GM, Tolkachjov SN. PMID: 42355922 [PubMed]
	Efficacy and Safety of PD-1 Inhibitor-Based Regimens in Patients with Melanoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Clin Med Kouris NI, Filippatos C, Lallas K, Spyropoulou S, Malandrakis P, Terpos E, Gavriatopoulou M, Ntanasis-Stathopoulos I. PMID: 42355889 [PubMed]
	Predicting Response to Immune Checkpoint Inhibitors in Melanoma: Emerging Approaches in Digital Pathology, Spatial Profiling and Machine Learning. Int J Mol Sci Banaszek J, B, Bara, Czajka A, Ciesielska D, Kleinrok J, Paj, Korolczuk A, Mazur M, Rusztyn K. PMID: 42352966 [PubMed - indexed for MEDLINE]
	Age-Stratified Long-Term Outcomes of Immune Checkpoint Inhibitors for Stage IV Melanoma and NSCLC in The Netherlands: A Population-Based Study. Cancers (Basel) Steenhuis EGM, van Disseldorp LM, Jacobs FJC, van Schayk N, Suijkerbuijk K, Louwman M, d'Hooghe JNS, Damhuis RAM, van Geffen WH. PMID: 42352551 [PubMed]
	Real-World Outcomes of Nivolumab Plus Ipilimumab in Metastatic Melanoma: A Stratified Analysis of First- and Second-Line Treatment. Cancers (Basel) Iurchenkov A, Danilova A, Shilo P, Stoliarov V, Rakhmanova P, Kanner I, Basharina A, Stroyakovskiy D. PMID: 42352526 [PubMed]
	Biomarkers in Melanoma: Updates in Prognosis and Management. Cancers (Basel) Crosby B, Guerra M, Crosby A, Linza B, Lourdault K, Essner R. PMID: 42352524 [PubMed]
	Neoadjuvant Therapy and the Evolving Management of Resectable Advanced Melanoma. Cancers (Basel) Papadopoulos N, Del Vecchio M, Spagnoletti A, Pigozzo J, Piccin L, Minisini A, Pravisano F, Roccuzzo G, Fava P, Cimminiello C. PMID: 42352510 [PubMed]
	Adjuvant Approaches in Fully Resected Stage III and IV Cutaneous Melanoma: Where Are We Now? Cancers (Basel) Piccin L, Guarneri V, Del Vecchio M, Spagnoletti A, Fava P, Roccuzzo G, Cimminiello C, Papadopoulos N, Minisini A, Costa J, Pigozzo J. PMID: 42352494 [PubMed]

Articles 1 - 20 / 45887

Page 1 of 2295



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy